May 2, 2019 8:31am

Q1/19 financial results: Intellia Therapeutics (NTLA) and Sage Therapeutics (SAGE)

Pre-open indications:  2 BUYs, 1 SELL and 3 TRADEs

Insight is also about putting into context what is relevant to expectation 


Members only. Please login.